• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, March 17, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Australian optometrists give feedback on Rodenstock MyCon myopia control lens

by Staff Writer
September 20, 2023
in Eye disease, Local, Myopia, Myopia control, Myopia control soft contact lenses, Myopia interventions, News, Ophthalmic Treatments, Progressive myopia
Reading Time: 3 mins read
A A
MyCon lens has three distinct zones: a central zone containing the patient’s prescription, a temporal zone of progressively increasing power up to 2.5 D, and a nasal zone of progressively increasing power up to 2.0 D.

MyCon lens has three distinct zones: a central zone containing the patient’s prescription, a temporal zone of progressively increasing power up to 2.5 D, and a nasal zone of progressively increasing power up to 2.0 D.

Share on FacebookShare on Twitter

 

German ophthalmic lens manufacturer Rodenstock released its MyCon myopia control spectacle lens into Australia in April this year and has since had positive reception from optometrists and patients.

According to the company, the lens is designed to correct myopia and reduce the rate of axial length elongation in children using peripheral defocus targeting the horizontal meridian of the retina. This ensures the child can see sharply at their point of focus.

The lens has three distinct zones:

  • A central zone, where the optical power corresponds to the wearer’s nominal refraction.
  • A temporal zone of progressively increasing power up to 2.5 D.
  • A nasal zone of progressively increasing power up to 2.0 D.

MyCon lenses are available in index 1.5, 1.6, 1.67, and 1.74 with hard coat and antireflection options including a blue light coating. A barrier to glasses uptake by children is the issue of appearance, with MyCon lens indices offering a sleek design alternative.

Since its release, MyCon lens has been acknowledged  as an accessible alternative compared to other myopia control methods such as eye-drops and contact lenses for children which are often associated with lower compliance rates.

“We started using MyCon Lenses earlier this year and everyone who has had other lens designs transitioning to Mycon have adapted to the Mycon lenses really well,” said Ms Sonya Wijaya, optometrist owner of Optical Insight in Doncaster, Victoria, and a regular presciber of MyCon.

“Options of high index for thinner lenses as well as premium coating have made a big difference in children’s compliance in wearing their spectacle correction.”

Another early adopter, Associate Professor Richard Vojlay who is optometrist owner of Collin and Kirk Optometrists in Thornbury, Victoria, stated that compliance rates are high, and children have adapted well to the lenses in a relatively short timeframe.

“The simplest modification to the child’s experience is to prescribe myopia control spectacles. No drops, no blurred vision, no glare sensitivity, no contact lenses, or cleaning regimes, just a replacement pair of spectacles. But spectacles that will reduce the rate of axial length elongation,” he said.

Vojlay said all myopia control treatments require some level of adaptation to the new visual environment and children can be incredibly tolerant of these changes. The responses to wearing MyCon lenses was no different.

“The initial reactions were positive with some disorientation from the peripheral blur, but that quickly settled as they focused on the clarity of the central vision. They usually adapted to the lenses within one to two weeks, learning to incorporate greater head movements to engage with peripheral viewing points. Certainly, these patients will have minimal difficulty adapting to multifocal lenses when they reach presbyopia,” he said.

“MyCon lenses are a welcome addition to the increasing range of myopia control spectacle treatments.”

More reading

Rodenstock MyCon myopia control lens launches in Australia

Rodenstock’s new myopia lens targets horizontal meridian

How premium Rodenstock lenses help practices provide a premium service

 

Related Posts

Aussie Rules players in Darwin are being hit by mystery eye infections. Image: AlazySM/stock.adobe.com.

Aussie Rules players struck down by mystery eye infections

by Staff Writer
March 17, 2026

Eyecare professionals in the Northern Territory are scratching their heads over an outbreak of eye infection that has hit dozens...

Optos ultra-widefield imaging will be on show at events in Western Australia and NSW. Image: Prime Creative Media.

Optos technology on show in upcoming events

by Staff Writer
March 16, 2026

Optos is encouraging eyecare professionals serious about advancing patient care and staying ahead in eye health technology to visit its...

The eye drops can quickly relieve tired, red eyes. Image: LimeSky/stock.adobe.com.

B+L announces launch of Lumify eye drops in Australia

by Staff Writer
March 16, 2026

Bausch + Lomb (B+L) has announced the Australian launch of Lumify redness reliever eye drops in April. The Lumify range...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited